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UbiquitinParkinson's disease (PD) is characterized by dopaminergic dysfunction and degeneration. DJ-1/PARK7 muta-
tions have been linked with a familial form of early onset PD. In this study, we found that human DJ-1 wild
type and the missense mutants M26I, R98Q, A104T and D149A were stable proteins in cells, only the
L166P mutant was unstable. In parallel, the former were not degraded and the L166P mutant was directly de-
graded in vitro by proteasome-mediated endoproteolytic cleavage. Furthermore, genetic evidence in ﬁssion
yeast showed the direct involvement of proteasome in the degradation of human DJ-1 L166P and the corre-
sponding L169P mutant of SPAC22E12.03c, the human orthologue of DJ-1 in Schizosaccharomyces Pombe, as
their protein levels were increased at restrictive temperature in ﬁssion yeast (mts4 and pts1-732) harboring
temperature sensitive mutations in proteasomal subunits. In total, our results provide evidence that direct
proteasomal endoproteolytic cleavage of DJ-1 L166P is the mechanism of degradation contributing to the
loss-of-function of the mutant protein, a property not shared by other DJ-1 missense mutants associated
with PD.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Parkinson's disease (PD) is associated with progressive loss of do-
paminergic neurons from the substantia nigra, and is characterized by
the presence of cytosolic ﬁlamentous inclusions known as Lewy bod-
ies and Lewy neurites, which are enriched in ﬁbrils of α-synuclein
[33]. The cause of PD remains unknown, and although the majority
of cases appear sporadic in incidence, rare monogenic forms of PD
have provided insight into the pathogenesis of the disease. Five
genes have been unambiguously linked to familial PD and include
α-synuclein/PARK1, PARKIN/PARK2, DJ-1/PARK7, PINK1/PARK6 and
LRRK2/PARK8 [34,46], for a data base of mutations on those genes
see PDmutDB, http://www.molgen.ua.ac.be/PDmutDB/default.cfm?
MT=0&ML=0&Page=Home.
DJ-1/PARK7 mutations are linked with autosomal recessive inheri-
tance and early-onset PD clinical manifestations. Pathogenic mutations
identiﬁed in DJ-1/PARK7 gene include CNVs (exonic deletions and trun-
cations), homozygous (L10P, M26I, E64D, E163K and L166P) and het-
erozygous (A39S, A104T and D149A) missense mutations, rareca e Instituto de Investigaciones
na de la Universidad Autónoma
ax: +34 91 585 4401.
.
l rights reserved.polymorphisms (R98Q, A171S) have also been identiﬁed in normal in-
dividuals and are not associated with PD [46].
DJ-1 is a member of the DJ-1/Pfp1/YajL(Thij) protein family [36]
and is a dimeric protein with a ﬂavodoxin-like helix–strand–helix
sandwich structure [23,58,66,24,32]. DJ-1 is ubiquitously expressed
and was initially identiﬁed as a potential oncogene cooperating in
the transformation activity of Ha-Ras [44]. DJ-1 has been implicated
in many pathways: regulation of transcription [55,53,67,52,69], bind-
ing to RNA [21,61], regulation of sumoylation [51], protein folding as
a chaperon [50,71,13], and cell death [27]. The DJ-1 protein is found to
be cytoprotective against oxidative stress suggesting that DJ-1 repre-
sents a sensor acting as an antioxidant and preventing apoptosis
[10,54,70,11,2,8,35,1]. The expression of DJ-1 positively correlates
with PKB/Akt activity and negatively with PTEN immunoreactivity
in primary breast cancer and non-small cell lung carcinoma samples
[28] and associates with PTEN leading to inhibition of its phosphatase
activity [29]. DJ-1 has also been implicated in cancer cell survival by
stabilization of HIF1 and regulation of AMPK, mTOR and the autopha-
gic pathway [62]. Recent evidence supports the possible role of DJ-1
in paraquat induced autophagy [17] and in a parallel pathway to
PINK that regulates mitoautophagy [30,25,59].
Due to the recessive inheritance of DJ-1 associated PD, it is consid-
ered likely that disease development is due to loss of function and ac-
cordingly point mutations are expected to lead to a loss of function of
the protein. Fitting with this hypothesis, DJ-1 L166P mutation
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stability in the cell [9,37,39,40,47,56,7,18]. DJ-1 M26I mutant may
also have increased degradation in the cell [7,56] while other groups
have found no effect of the M26I mutation on protein stability
[40,6,68]. A104T and D149A hDJ-1 mutants were also shown to ex-
hibit increased rates of degradation in the cell [7], but other groups
found that they are stable [40,6,67,68].
Here we have investigated the degradation of human DJ-1 (hDJ-1)
wild type and ﬁve of its missense point mutants (M26I, R98Q, A104T,
D149A and L166P). The results have shown that only hDJ-1 L166P
protein had an increased rate of degradation in the cell. Furthermore,
hDJ-1 L166P was directly degraded without prior ubiquitylation by
the 20S (and 26S) proteasome in vitro by an endoproteolytic mecha-
nism. Finally, we showed that hDJ-1 L166P and the corresponding
L169P mutant of DJ-1 Schizosaccharomyces Pombe (S. pombe) ortholo-
gue, SPAC22E12.03c [36], were stabilized at restrictive temperature in
S. pombe harboring temperature sensitive (Ts) mutations in proteaso-
mal subunits.
2. Materials and methods
2.1. Plasmid constructs
Human wild type DJ-1 cDNAwas obtained by PCR from the IMAGE
clones (IMAGE clone ID: 2901102: MGC:5243, GenBank, BC008188)
with the appropriate oligonucleotides (forward BamH1-hDJ-1; 5′
GGAAGGATCCATGGCTTCCAAAAGAGCTCTGG 3′, reverse XhoI-hDJ-1
5′ GCGCCTCGAGCTAGTCTTTAAGAACAAGTGGAGCC 3′) and inserted
into pRSETA vector digested with BamHI/XhoI. The different mutants
M26I, R98Q, A104T, D149A and L166P were obtained with Quick-
Change™ Site-Directed Mutagenesis Kit from Statagene with the
following oligonucleotides: forward hDJ-1 M26I; 5′ CCCTGTA-
GATGTCATCAGGCGAGCTGGGATT 3′, reverse hDJ-1 M26I; 5′AATCC-
CAGCTCGCCTGATGACATCTACAGGG 3′; forward hDJ-1 R98Q; 5′
GGAGCAGGAAAACCAGAAGGGCCTGATAGC 3′, reverse hDJ-1 R98Q;
5′ GCTATCAGGCCCTTCTGGTTTTCCTGCTCC 3; forward hDJ-1 A104T;
5′ GGGCCTGATAGCCACCATCTGTGCAGG 3′ reverse hDJ-1 A104T; 5′
CCTGCACAGATGGTGGCTATCAGGCCC 3′; forward hDJ-1 D149A; 5′
GAATCGTGTGGAAAAAGCCGGCCTGATTCTTACAAGC 3′ reverse hDJ-
1 D149A; 5′GCTTGTAAGAATCAGGCCGGCTTTTTCCACACGATTC 3′; for-
ward hDJ-1 L166P; 5′GCTTCGAGTTTGCGCCCGCAATTGTTGAAGCCC 3′,
reverse hDJ-1 L166P; 5′GGGCTTCAACAATTGCGGGCGCAAACTCGAAGC
3′. GST-DJ-1 L166P was obtained by PCR ampliﬁcation from pRSET-A
hDJ-1 L166Pwith the forward BamH1-hDJ-1 and reverse XhoI-hDJ-1 ol-
igonucleotides, and cloning into the BamH1/XhoI sites of pGEX4T-1.
GST-hDJ-1 L166P-GST construct was obtained by PCR ampliﬁcation of
hDJ-1 L166P with the appropriate oligonucleotides (forward BamH1-
hDJ-1, and reverse EcoRI Non stop-hDJ-1; 5′TTGCTCCGAATTCGTCTT-
TAAGAACAAGTGGAGCCTTCAC 3′) and cloned into pGEX4T-1 digested
with BamHI/EcoRI. A cassette containing GST protein was obtained by
PCR ampliﬁcation with the following oligonucleotides; forward SalI-
GST; 5′ CCACGTCGACCGATGTCCCCTATACTAGGTTATTG 3′, and reverse
NotI-GST; 5′ GGTTGCGGCCGCTCAACGCGGAACCAGATCCGATTTTGG 3′,
this cassette was cloned into pGEX4T-1 digested with SalI/NotI, in
frame with the carboxy-terminus of hDJ-1 L166P Non-stop previously
cloned into the same plasmid.
For expression in eukaryotes, hDJ-1 was digested from the
pT7T3D-PAC vector (IMAGE vector) with NotI/XhoI, and cloned di-
rectly into the NotI/XhoI sites of pCMV-Sport6, hDJ-1 mutations
were obtained with QuikChange™ Site-Directed Mutagenesis Kit
from Stratagene with the oligonucleotides described above.
For DJ-1 expression in S. pombe, SPAC22E12.03c (SpDJ-1) gene
was ampliﬁed from S.pombe genomic DNA by PCR with the following
oligonucleotides; forward BamHI-SpDJ-1; 5′GAGCGGATCCATGG-
TAAAGGTTTGCCTATTTGTTGC 3′, and reverse XhoI Non-stop-SpDJ-1;
5′GGGCTCGAGCGCAAGGGCATACTAAGAG 3′, and cloned into thepcDNA™3.1/V5-His®Topo® TA vector (Invitrogen) by digestion
with BamHI/XhoI, the cassette SpDJ-1-V5-His was ampliﬁed by PCR
with the following oligonucleotides; forward PstI-SpDJ-1; 5′
GCCGCTGCAGATGGTAAAGGTTTGCCTATTTGTTGC 3′, and reverse
SmaI-V5-His; 5′GGGCCCGGGTCAATGGTGATGGTGATG 3′, and cloned
into pJRL2-3X-Leu vector [42] by digestion with PstI/SmaI. The SpDJ-
1 L169P mutant (homologous position to human L166P) was obtained
with QuickChange™ Site-Directed Mutagenesis Kit from Statagene
using the following oligonucleotides: forward SpDJ-1 L169P; 5′
CCCGGTACTGCAATGCTTTTTGGTCCAAAATTATTGGAGCAGGTTGCAAGC
3′, and reverse SpDJ-1 L169P; 5′GCTTGCAACCTGCTCCAA-
TAATTTTGGACCAAAAAGCATTGCAGTACCGGG3′. For hDJ-1 expres-
sion in S. pombe, hDJ-1 cDNA was ampliﬁed by PCR with the
corresponding oligonucleotides (forward PstI-hDJ-1; 5′ GCGACTG-
CAGATGGCTTCCAAAAGAGCTCTGG 3′, and reverse SmaI-hDJ-1; 5′
GAGCCCGGGCTAGTCTTTAAGAACAAGTGGAGCC 3′), and cloned
into pJRL2-3X-Leu vector by digestion with PstI/SmaI.
2.2. Cell culture, transfections and western blotting
N2A (mouse neuroblastoma) cells were transiently transfected
with hDJ-1 constructs with Lipofectamine reagent (Invitrogen). Pro-
tein turnover was studied by treatment of cells with cicloheximide
(20 μg/ml) for the times indicated. Total cell extracts prepared by direct
lysis of cells in SDS-loading buffer were separated on 12% SDS-PAGE,
transferred to nitrocellulose and immunoblotted with anti-DJ-1 mono-
clonal antibody (MBL. Clone 3E8), α-Tubulin (DM1A, Sigma, dil.
1:1000) monoclonal antibody was used for loading control. Blots were
developed by direct capture of chemiluminescence with DNR
MF-ChemiBIS 3.2 bioimaging system and quantiﬁcation with Totallab
TL100 software. Results are expressed as mean±s.e.m. for a minimal
number of tree independent experiments.
2.3. Protein puriﬁcation and generation of polyclonal antibodies
Rat liver 20S was puriﬁed as described [5] and 26S proteasome
was either bought from Biomol or puriﬁed as described [20]. Wild
type His-hDJ-1 and the respective mutants were puriﬁed by nickel-
afﬁnity chromatography (Qiagen). GST DJ-1 fusion constructs were
puriﬁed on glutathione-Sepharose (GE Healthcare Life Sciences). All
proteins were dialyzed against 25 mM Tris–Cl pH7.5 and store frozen
at −70 °C until use. Polyclonal antibodies against human DJ-1 were
obtained by immunization of rabbits with puriﬁed recombinant
human wild type DJ-1 or mutant L166P (100 μg per injection), as de-
scribed previously [4,38].
2.4. DJ-1 secondary structure
Far-UV circular dichroism (CD) spectra of the DJ-1 recombinant
proteins were obtained by averaging over 5–20 scans with a step
size of 0.5 nm on an AVIV model 62DS CD spectrometer equipped
with a thermoelectric temperature controller. All measurements
were performed in Hellma quartz cuvettes with a path length of 0.1
or 0.5 cm. For thermal denaturation, protein solutions were heated
to 80 °C and CD spectra were recorded after stabilization as described
above.
2.5. In vitro degradation assays
Degradation reactions with puriﬁed proteasome contained in a
ﬁnal volume of 20 μl: 20 mM Hepes-NaOH pH 7.4, 2 mM EDTA,
1 mM EGTA, 4 μM of monomeric puriﬁed protein substrates and
69.4 or 50 nM of puriﬁed rat liver 20S or 26S proteasome, respectively.
Reactions were incubated at 37 °C for the times indicated and stopped
with concentrated SDS-PAGE sample buffer. Control reactions con-
tained no proteasome or 10 μM lactacystin (proteasome inhibitor).
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Fig. 1. Degradation of hDJ-1 wild type and missense mutants in N2A transfected cells. N2A cells were transiently transfected with the indicated untagged hDJ-1 constructs and 48 h
after transfection were treated with cycloheximide (CHX) either in the absence or in the presence of 10 μM Lactacystin for the times indicated. A, panels show representative immunoblots
with anti-hDJ-1monoclonal antibody of hDJ-1 wild type (wt), M26I, R98Q, A104T andD149A transfected cells. B, panels show the results obtained with transfected hDJ-1 L166P developed
with anti-hDJ-1monoclonal antibody, the panels labeledwithmDJ-1 are similar samples from untransfected cells developedwith rabbit polyclonal anti-DJ-1 antibodies to detect the endog-
enous mouse DJ-1 (mDJ-1) protein. Anti-tubulin antibodies were used as protein loading controls. Quantiﬁcations are shown in the right graphs as means±s.e.m. from three different
experiments.
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were stained, destained and dried under vacuum; or transferred to ni-
trocellulose and developed with anti-DJ-1 monoclonal (MBL, Clone
3E8) or our in-house produced polyclonal antibodies (anti-GST or anti-
DJ-1). Quantitation was performed using the Quantity-one software
(Biorad SA, Madrid, Spain).
2.6. Peptide analysis of hDJ-1 L166P degradation by the proteasome
Degradation reaction mixtures were stopped with 10 volumes of
0.1% TFA and subjected to reverse-phase HPLC on a 4.6×250-mm
Vydac C18 column (Vydac, Hesperia, CA) in 0.1% TFA with a ﬂow rate
of 1 ml/min and resolved with a linear gradient 0–70% acetonitrile in
0.1% TFA. Eluted fractions were manually collected and dried in a
Speed-Vac. Peptide analysis and identiﬁcation was performed by
MALDI-MS/MS, as described [15].
2.7. Gel-ﬁltration chromatography of S. pombe DJ-1 wild type and
mutant L169P
Wild-type S. pombe PR100 cells were transformed with the corre-
sponding pJRL2 constructs of S. pombe DJ-1 wild type or the mutant
L169P and grown under selective conditions on minimal media
(EMM) with 5 μg/ml thiamine to repress the nmt1 promoter [43].
Transformants were grown at 25 °C on EMM without thiamine to
allow protein expression for 36 h. Cells were harvested, centrifuged
and resuspended in 5 volumes (wet weight/volume) of cell lysis buffer:
25 mM Tris–Cl pH7.5, 150 mM NaCl, 0.5% NP-40, 10 μM leupeptin,
1 μg/ml pepstatin and 1 mM PMSF. Acid-washed glass beads
(0.5 mm, Sigma G-9268) were added (1 wet weight). Cells werebroken by vigorous shaking (5 cycles: 6.5 m/s for 60 s with 5 min
rest period between runs at 4 °C) in a FastPrep®-24 (MP Biomedi-
cals, Solon, Ohio, USA). Cell debris and glass beads were pelleted by
centrifugation at 14,000×g for 5 min at 4 °C. The supernatant was
clariﬁed by further centrifugation at 14,000×g for 30 min at 4 °C. Al-
iquots of the supernatants then were applied to a TSK-GEL G3000-
SW (05789, Tosoh Bioscience LLC) gel ﬁltration column equilibrated
in 25 mM Tris–Cl, pH 7.5 and 150 mM NaCl. One-minute fractions
were collected at 0.25-ml/min ﬂow rate, and analyzed by 12%
SDS-PAGE followed by Western immunoblotting with anti-V5
(1:2000, Invitrogen). Gel ﬁltration standards were from Bio Rad.
2.8. DJ-1 stability in proteasomal-subunits Ts mutants of S. pombe
S. pombe proteasome Ts mutants were grown at permissive tem-
perature and transformed with the corresponding pJRL2 DJ-1 con-
structs in the presence of thiamine to repress expression. The
plasmids were transformed into Ts proteasomal mutants, mts4 with
a mutation in the Rpn1 (PSMD2 S2, p97 HRD2, NAS1) subunit of the
19S complex of the 26S proteasome [65] and pts1-732 strain a Ts mu-
tant of the β5 catalytic subunit of the 20S proteasome [57] under se-
lective conditions on EMM, as described above [43]. Cells were grown
at 25 °C in EMM in the presence of 5 μg/ml thiamine until exponential
phase (0.6–0.7 OD660/ml), thiamine was removed and the culture
continued for 36 h to allow protein expression from the transfected
plasmids. Culture was then divided into two halves; one half was
kept growing at 25 °C and the other half was shifted to 37 °C. Cells
were harvested at the times indicated, centrifuged and resuspended
in 5 volumes (wet weight/volume) of cell lysis buffer (10 mM sodium
phosphate pH 7.4, 1% TritonX-100, 1% SDS, 2 mM EDTA, 150 mM NaF,
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PMSF) and cell-free extracts were prepared as described above. Ali-
quots of the extracts were loaded onto 12% SDS-PAGE, transferred
to nitrocellulose and processed for immunoblot with anti-V5
(1:2000, Invitrogen) or our own anti-DJ-1 antibodies (1:2000) using
anti α-Actin (1:2000, AC-40, Sigma) to control for protein load, as de-
scribed above.
3. Results
3.1. In situ degradation of hDJ-1 in mammalian cells
To test the degradation rates of hDJ-1 and its missense mutants,
we transfected the hDJ-1 untagged constructs into N2A, a mouse neu-
roblastoma cell line, and after transfection cells were treated with cy-
cloheximide (CHX). The hDJ-1 wild type and its variants M26I, R98Q,
A104T, and D149A were not signiﬁcantly degraded after treatment of
the cells for 24 h with CHX. (Fig. 1A). As reported previously, trans-
fected hDJ-1 L166P (Fig. 1B) is rapidly degraded and proteasome inhi-
bition slowed hDJ-1 L166P degradation, but it did not completely
inhibit its degradation, as it has been previously reported
[39,47,18,48].
3.2. In vitro DJ-1 degradation by the 20S and 26S proteasome
Ubiquitin-independent and proteasomal dependent degradation
is apparently responsible of the degradation of an increasing number
of proteins [26] and in vitro can be accomplished directly by the 20S
proteasome, or the 26S proteasome. As a consequence, we decided
Table 1
Summary of peptide analysis of hDJ-1 L166P released by degradation with 20S proteasome.
HPLC PEAK numbera Start End Sequence Exp_mass Cal_mass
22 5 16 RALVILAKGAEE 1268, 851 1268, 745
14 6 12 ALVILAK 726, 4322 726, 5003
14 6 15 ALVILAKGAE 983, 4786 983, 6015
14 6 16 ALVILAKGAEE 1112, 539 1112, 644
19 6 18 ALVILAKGAEEME 1388, 807 1388, 722
16 10 24 LAKGAEEMETVIPVD 1600, 925 1600, 802
14 11 24 AKGAEEMETVIPVD 1487, 678 1487, 718
23 11 26 AKGAEEMETVIPVDVM 1733, 947 1733, 822
14 12 24 KGAEEMETVIPVD 1416, 633 1416, 681
27 12 34 APAIVEALNGKEVAAQVKAPLVL 2300, 518 2300, 347
15 19 27 TVIPVDVMR 1028, 656 1028, 569
14 29 42 AGIKVTVAGLAGKD 1298, 665 1298, 756
5 59 68 EDAKKEGPYD 1150, 493 1150, 514
14 69 79 VVVLPGGNLGA 994, 547 994, 5811
15 69 84 VVVLPGGNLGAQNLSE 1565, 974 1565, 841
15 78 90 GAQNLSESAAVKE 1302, 68 1302, 64
14 83 94 SESAAVKEILKE 1302, 684 1302, 703
12 85 94 SAAVKEILKE 1086, 645 1086, 628
20 107 117 AGPTALLAHEI 1091, 669 1091, 598
12 107 115 GPTALLAH 778, 4894 778, 4337
19 108 117 GPTALLAHEI 1020, 63 1020, 56
16 144 153 NRVEKDGLIL 1155, 761 1155, 661
20 148 162 KDGLILTSRGPGTSF 1547, 954 1547, 831
27 150 159 GLILTSRGPG 969, 6358 969, 5607
19 150 162 GLILTSRGPGTSF 1304, 79 1304, 709
18 150 163 GLILTSRGPGTSFE 1433, 797 1433, 751
27 150 168 GLILTSRGPGTSFEFAPAI 1933, 107 1933, 031
28 150 169 GLILTSRGPGTSFEFAPAIV 2032, 233 2032, 099
28 150 170 GLILTSRGPGTSFEFAPAIVE 2161, 2 2161, 14
22 154 168 TSRGPGTSFEFAPAI 1536, 8 1536, 76
22 155 173 SRGPGTSFEFAPAIVALN 1832, 98 1832, 94
22 156 169 RGPGTSFEFAPAI 1348, 731 1348, 678
22 156 170 RGPGTSFEFAPAIV 1447, 51 1447, 45
24 163 182 EFAPAIVEALNGKEVAAQVK 2083, 304 2083, 131
18 165 182 APAIVEALNGKEVAAQVK 1807, 176 1807, 02
28–29 167 182 AIVEALNGKEVAAQVK 1639, 065 1638, 93
20 169 189 VEALNGKEVAAQVKAPLVLKD 2191, 54 2191, 26
20 171 189 ALNGKEVAAQVKAPLVLKD 1963, 19 1963, 15
28–29 171 182 ALNGKEVAAQVK 1226, 802 1226, 698
20 171 187 ALNGKEVAAQVKAPLVL 1721, 141 1721, 009
20 172 187 LNGKEVAAQVKAPLVL 1649, 058 1648, 988
19 177 187 VAAQVKAPLVL 1107, 714 1107, 702
11 178 186 AAQVKAPLV 895, 618 895, 5491
18 178 187 AAQVKAPLVL 1008, 629 1008, 633
18 179 187 AQVKAPLVL 937, 5864 937, 596
a Reference to HPLC peak number shown in Supplementary Fig. 1.
Exp_mass: experimental mass, cal_mass: calculated mass, both expressed in Da.
Pro residues located close to P1 cleavage sites by the proteasome are labelled in bold and italics.
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mutant by the proteasome. First we checked the structure of the pu-
riﬁed recombinant DJ-1 proteins that would be used for the degrada-
tion experiments. The CD proﬁles of puriﬁed recombinant hDJ-1 wild
type and L166P under native conditions (Fig. 2A) and after heat-
denaturation (Fig. 2B) are in perfect agreement with previous reports
that indicate that DJ-1 L166P has no signiﬁcant secondary structure
under native conditions and that heat denaturation of hDJ-1 wild
type produce an irreversibly lost of its secondary structure [47,50]. In-
cubation of hDJ-1 wt (native or heat denatured) and L166P with 20S
proteasome showed (Fig. 2C) that DJ-1 L166P was rapidly degraded
by the proteasome, while the native or heat-denatured DJ-1 wild
type was not signiﬁcantly degraded. Heat-denatured DJ-1 L166P
was also readily degraded by the proteasome (data not shown). Fur-
thermore, we were able to detect some intermediates in the degrada-
tion of DJ-1 L166P when its degradation by the proteasome was
analyzed by immunoblot (Fig. 2D). Those degradation intermediates
showed no clear N-terminal aminoacid when analyzed by N-
terminal Edman degradation, likely due to heterogeneity in their N-terminal sequence as expected for the lack of speciﬁcity of proteaso-
mal cleavage (data not shown). We next tested the degradation of
the recombinant DJ-1 wild type and the missense mutants by incuba-
tion with the 20S and 26S proteasome and detection by immunoblot
with anti DJ-1 antibodies, results are presented in Fig. 3. In agreement
with the results shown above, DJ-1 wild type was not signiﬁcantly de-
graded by the 20S (Fig. 3A) or the 26S proteasome (Fig. 3B), and the
DJ-1 L166P was degraded by both 20S and 26S proteasome (Fig. 3A
and B, respectively), note that some intermediate products of degra-
dation were also detected by immunoblot analysis because of its
higher sensitivity, as shown before (Fig. 2D). The other DJ-1 missense
mutants under study M26I, R98Q, A104T and D149A were not signif-
icantly degraded by incubation with either the 20S or 26S protea-
some, behaving like DJ-1 wild type.
3.3. Mechanism of degradation of DJ-1 L166P by the 20S proteasome
To determine the sites of cleavage of DJ-1 L166P by the protea-
some, degradation reactions were analyzed by reverse-phase HPLC
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Fig. 4. Graphical representation of the digestion map generated from degradation of recombinant DJ-1 L166P by 20S proteasome. The complete aminoacid sequence of hDJ-1 L166P
(Pro labeled in red) is presented. Black bars below the protein sequence represent identiﬁed peptides (Table 1), ordered from their N-terminus. Contiguous peptides where both N
and C terminal released peptides have been identiﬁed are labeled with different colors.
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representative reverse phase HPLC proﬁle of peptides generated by
proteasome digestion of DJ-1 L166P is presented in Supplementary
Fig. 1. Eluted peptides were identiﬁed by MALDI-TOF MS/MS. The re-
sults obtained are summarized in Table 1 the average length of the
identiﬁed peptides that were released by proteasomal digestion was
13.7±3.9 aminoacids. A graphical representation of the map of0 60 120 180 24Time (min)
GST-hDJ-1 L166P-GST
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GST-hDJ-1 L166P 47 kDa
I
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Fig. 5. Proteasomal degradation of N-capped and double N and C-capped DJ-1 L166P. Recom
two GST ﬂanking the N- and C-terminus (GST-DJ-1 L166P–GST) were incubated for the time
polyclonal antibodies (A) and afterwards with anti-GST antibodies (B). Lane labeled GST, con
labeled+Lacta contained GST-DJ-1 L166P–GST or GST-DJ-1 L166P incubated for 120 or 240identiﬁed peptides respect to the sequence of DJ-1 L166P is presented
in Fig. 4. While we did not cover the entire sequence of DJ-1 L166P,
the relative abundance of identiﬁed peptides around the location of
the L166P mutation indicated that this region could be a preferential
site of cleavage by the 20S proteasome. These results and the fact that
we could detect intermediates (Figs. 2 and 3) in the degradation of
DJ-1L166P by immunoblot suggested that the cleavage of DJ-10 0 30 60 120
GST-hDJ-1 L166P GST
240 120
+ Lacta
240
blot anti- DJ-1
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binant puriﬁed hDJ-1 L166P ﬂanked at its N-terminus by GST (GST-DJ-1 L166P) or with
s indicated with 20S proteasome and analyzed by Western immunoblot with anti-DJ-1
tained GST incubated with the proteasome for 240 min as a control reaction. The lanes
min (as indicated) with the proteasome in the presence of 10 μM Lactacystin.
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Fig. 6. Gel ﬁltration analysis of S. pombe DJ-1 wild type and mutant L169P. Cell-free ex-
tracts of S. pombe PR100 expressing S. pombe DJ-1 wild type (wt) or mutant L169P
tagged with V5 epitope were individually analyzed by HPLC gel ﬁltration as described
under Experimental. The fractions were analyzed by SDS/PAGE, and the proteins
detected by Western immunoblotting with anti-V5 antibodies. The indicated positions
of the native molecular mass markers from Bio Rad were determined by independent
column chromatography.
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endoproteolytic mechanism we generated single N-terminal capped
(GST-DJ-1 L166P) and double N-and C-terminal capped (GST-DJ-1
L166P-GST) protein constructs. As shown in Fig. 5, N and C-terminal
GST capped DJ-1 L166P protein were degraded by the 20S protea-
some generating GST-DJ-1 intermediates (Fig. 5A) and GST (Fig. 5B)
with mobilities similar to the intermediates generated by proteaso-
mal degradation of single N-capped GST-DJ-1 L166P (Fig. 5A). These
results showed that DJ-1 L166P was endoproteolytically cleaved by
the 20S proteasome.
3.4. In situ degradation of DJ-1 in yeast
S. pombe is broadly used in genetic, cell biology, and biochemical
studies and an orthologue of mammalian DJ-1, SPAC22E12.03c
(SpDJ-1), was inferred by phylogenetic studies of protein sequence
alignments [36]. A sequence alignment of SpDJ-1 and hDJ-1 is pre-
sented in Supplementary Fig. 2, in particular L169 in S. pombe DJ-1
would be in the orthologous position to L166 of hDJ-1 and should
also disrupt Helix 7 in the dimer interface. Unfortunately we have
been unable to perform the in vitro characterization of SpDJ-1 wild
type and L169P because the recombinant proteins went into inclusion
bodies when expressed in E. coli and its solubilisation required treat-
ment with 6 M urea. Therefore, we cloned SpDJ-1 wild type and SpDJ-A
Anti V5
β-Actin
Anti DJ-1
mts-4
24ºC 37ºCT
-Thiamine + - - - - - + - - - -
6Time (h) 0 4 108 60 4 108
B
+
Fig. 7. Stabilization and accumulation of hDJ-1 L166P and S. pombe DJ-1 L169P in temperatur
were transformed with the indicated DJ-1 constructs: untagged hDJ1 wild type (wt) or hDJ-1
24 °C to stationary phase in the presence (+) or in the absence (−) of Thiamine (vitamin B
logarithmic phase at 24 °C and thereafter either kept growing at 24 °C or heat stressed by s
times at 24 °C or after the shift to the restrictive temperature were probed by Western imm
indicated. Anti β-actin antibodies were used as protein loading control.1 L169P in appropriate vectors for expression in S. pombe. Their native
molecular weight was characterized by HPLC gel ﬁltration analysis of
cell-free extracts prepared form S. pombewild type PR100 transformed
with S. pombe wild type and L169P mutant tagged with V5-epitope. As
shown in Fig. 6, S. pombe DJ-1 wild type eluted with a relative native
molecular weight of 42 kDa (similar to hDJ-1), while the S. pombe
L169P elutes with an apparent native molecular weight of 20 kDa (sim-
ilar to hDJ-1 L166P). These results indicated that S. pombeDJ-1wild type
behaved like a dimer, while the L169P mutant was likely a monomer,
conﬁrming that the L169P mutation in SpDJ-1 disrupted protein
dimerization.
To test genetically if the proteasome was required for DJ-1 degra-
dation, we examined the level of expression of the human and ﬁssion
yeast DJ-1 wild type and L166P or L169P protein constructs in mts4
yeast cells that have a Ts mutation in a regulatory subunit of the pro-
teasome [65] and in pts1-732 cells that have a Ts mutation in the β5
catalytic subunit of the 20S proteasome [57]. At permissive tempera-
ture the steady state levels of expression of hDJ-1 L166P and SpDJ-1
L169P were markedly reduced in both ﬁssion yeast Ts mutants com-
pared to their respective wild type DJ-1 proteins (Fig. 7A and B,
24 °C), indicating that both human and ﬁssion yeast mutants seemed
to be unstable. At restrictive temperature (37 °C) the levels of expres-
sion of hDJ-1 and SpDJ-1 wild type did not change signiﬁcantly during
the time course after temperature shift, while we observed a net ac-
cumulation of both hDJ-1 L166P and SpDJ-1 L169P (Fig. 7A and B)
in mts4 and pts1-732. Collectively, these results showed that degra-
dation of the hDJ-1 L116P and SpDJ-1 L169P requires the proteasome.
Even under the restrictive temperature conditions where proteasome
function is completely blunted, we were unable to detect by immuno-
blot any DJ-1 proteins with high molecular weight that could be an
indication of post-translational modiﬁcation by ubiquitylation of DJ-1.
4. Discussion
DJ-1 wild type protein was a rather stable protein in the cell. We
have shown here that DJ-1 wild type protein levels remain essentially
unchanged after 24 h of incubation of cells with CHX, similar results
have also been reported previously using either CHX [37] or by
pulse-chase experiments with 35S Met/Cys [40] and more recently
by SILAC pulse-chase experiments and MS analysis [49]. The PD mis-
sense mutations M26I, A104T, D149A and the physiological variant
R98Q do not affect dimer formation or the secondary structurehDJ-1
L166P 24 kDa
hDJ-1
wt 24 kDa
SpDJ-1
wt 23 kDa
SpDJ-1
L169P 23 kDa
pts1-732
-- - - - - + - - - -
60 4 108 60 4 108
24ºC 37ºC
β-Actin
42 kDa
e sensitive proteasome mutants of S. pombe. S. pombe strains mts4 (A) and pts1-732 (B)
L166P, and V5-tagged S. pombe DJ-1 wild type (wt) or DJ-1 L169P. Cells were grown at
1) to induce protein expression, then diluted and grown in the absence of thiamine to
hifting to 37 °C, for the times indicated. Samples taken before (0) and at the indicated
unoblotting with anti DJ-1 polyclonal antibodies or anti-V5 monoclonal antibodies, as
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aging structure respect to wild type [19,31]. These DJ-1 variants
were also rather stable proteins in the cell, similar to DJ-1 wild type
(Fig. 1). These results are in agreement with the results reported pre-
viously [40,6,67,68].
The DJ-1 L166Pmissensemutant has been clearly demonstrated to
be unstable [9,37,39,40,47,56,7,18,48] and we obtained similar re-
sults. As reported previously, we also found that proteasome inhibi-
tion did not completely prevent the degradation of hDJ-1 L166P
(see above cited references), but the remaining degradation rate
after proteasome inhibition cannot be attributed to the autophagic
pathway, as CHX treatment blocks autophagy [14]. Furthermore,
treatment with different inhibitors of the autophagic pathway
(3-methyl-adenine, NH4Cl, chloroquine) fail to prevent hDJ-1
L166P degradation in our experimental conditions and similar re-
sults have also been reported previously [39,47,7]. Accordingly,
another pathway of degradation, not mediated by the protea-
some or the lysosome, may also play a minor quantitative role
in hDJ-1L166P degradation.
The obvious mechanism of DJ-1 L166P degradation by the protea-
some pathway could imply its poly-ubiquitylation and targeting to
degradation by the 26S proteasome. Previous reports [39,40,47,72]
have failed to detect appropriate levels of poly-ubiquitylated DJ.1
L166P after treatment of cells with proteasome inhibitors with or
without co-transfection with tagged ubiquitin and immunoprecipita-
tion, and we also were unable to detect its ubiquitylation in yeast pro-
teasome Ts mutants under restrictive temperature. Recently it has
been reported that over-expression of TRAF6 promotes K6, K27 and
K29 poly-ubiquitylation of DJ-1 L166P [72], but the relevance of
these unusual ubiquitylation in hDJ-1 L166P degradation under phys-
iological levels of expression remains to be established. The results
presented here show clearly that DJ-1 L166P can be directly degraded
in vitro by the 20S and 26S proteasome; in contrast DJ-1 wild type or
any of the other missense mutants (M26I, R98Q, A104T and D149A)
were not signiﬁcantly degraded. The direct degradation of the DJ-1
L166P mutant by the proteasome could be understood because this
mutant protein is an unfolded protein lacking tertiary and quaternary
structure, properties in common with many proteins that are direct
substrates of the proteasome [26]. While the above interpretation is
essentially correct, we think that it can be further discussed as heat
denatured DJ1 wild type (Fig. 2) that also lacked secondary, tertiary
and quaternary structures and yet it was not directly degraded by
the proteasome, similar results were obtained with heat denatured
M26I, R98Q, A104T and D149A hDJ-1 mutants (data not shown).
These results suggested to us that the L166P mutation apart from
the effects on protein structure could promote a preferential site of
cleavage by the proteasome. The suggestion was also supported by
the relative greater abundance of identiﬁed peptides released by pro-
teasomal digestion that are derived from the DJ-1 protein region
where the mutation L166P resides. The Pro 166 residue (see Table 1
and Fig. 4) was at position P3 for 3 identiﬁed peptides release by pro-
teasome digestion, at P4 in 2 peptides, and in one peptide each where
the Pro 166 residue was located at positions P5 and P7 respect to the
C-terminal cleavage site (P1) of the proteasome. Supporting the
above rationale are studies showing that proteasome preferred cleav-
age sites (P1) are preceded by a Pro residue located at positions P3 to
P7, as shown in the study of direct degradation of ornithine decarbox-
ylase by the 26S proteasome [60]. Furthermore, Pro in P4 position
(Pro-hydrophobic-X-Tyr/hydrophobic) is a preferred cleavage motif
not speciﬁc to a single catalytic subunit of the proteasome, as deduced
from the study of the degradation of enolase1 by the yeast 20S pro-
teasome [45]. Note also that the preference of proteasome for cleav-
age at a certain distance from a Pro residue was also reﬂected in the
complete set of identiﬁed peptides resulting from proteasomal degra-
dation of DJ-1 L166P (see Table 1). If the suggestion was correct, it
could be predicted that the cleavage of DJ-1 L166P by the proteasomeshould be endoproteolytic, and we have shown (Fig. 5) that N-capped
DJ-1 L166P and double N- and C-terminal capped DJ-1 L166P were di-
rectly degraded by the proteasome, clearly supporting the endopro-
teolytic mechanism. The endoproteolytic mechanism is likely
responsible of the generation of intermediate proteolytic products
of DJ-1 L166P. Proteasomal degradation is generally highly processive
without the net formation of intermediates [63]. Nevertheless, in vitro
studies of proteasomal degradation of different protein substrates: ly-
sozyme [64], Tau [12], PolyQ ﬂuorescent proteins [22], IκBα [3] and
processing of p105 NFκB precursor to p50 [41] have also shown the
appearance of degradation intermediates. Further degradation of
those intermediate products is likely due to the exposure of additional
cryptic sites of cleavage leading to the generation of smaller products
by the proteasome. The degradation intermediates observed in vitro
for proteasomal degradation of soluble proteins are unlikely to be ob-
served in vivo, either because proteasomal degradation ismore efﬁcient
in vivoor by the concurrent action of other cellular proteases. Collective-
ly all these data clearly suggested that the L166P mutation apart from
disrupting DJ-1 structure also promotes a new proline-directed protea-
somal cleavage. Nevertheless, due to the lack of speciﬁcity of proteaso-
mal degradation, the lack of secondary, tertiary and quaternary
structure is the main determinant for the degradation of DJ-1 L166P
by the proteasome.
To further proof the role of proteasome in the degradation of
hDJ-1 L166P, and in order to have direct genetic evidence, we used
S. pombe proteasome Ts mutants and the results obtained (Fig. 7)
clearly showed the role of proteasome in the degradation of hDJ-1
L166P, as its protein levels increased at restrictive temperature
while the protein levels of hDJ-1 wild type were unaffected. Further-
more, we have also shown that a synonymous mutation (L169P) in
SpDJ-1 orthologue, which also behaved as a monomer under native
conditions, was also unstable and its protein levels increased at re-
strictive temperature in S. pombe proteasome Ts mutants.
In summary, we have shown that DJ-1 wild type and the missense
mutants M26I, R98Q, A104T and D149A are stable proteins in the cell
and those mutant proteins do not ﬁt into lost of function mutation
due to an increased degradation rate of the mutant proteins in the
cell. Furthermore, it has been shown recently that DJ-1 D149A be-
comes resistant to cleavage by caspase6 [16]. In contrast, DJ-1 L166P
mutant as a direct consequence of itsmisfolded conformation, impaired
homo oligomerization, becomes a direct substrate for endoproteolytic
cleavage by the 20S/26S proteasome not requiring prior ubiquitylation
for its degradation. The genetic evidence obtained in yeast clearly
showed that proteasome pathway is involved in the degradation of
this mutant protein in the cell. Strongly reduced levels of expression
due to direct proteasomal degradation of DJ-1 L166P together with its
poor chaperone activity [13] clearly contribute to the loss of function
phenotype of this mutation in the pathogenesis of PD.
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